Valiltramiprosate for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Feb 2021: Trial registered, NCT04770220
  2. 19 May 2021: Trial started, NCT04770220

The trials

NCT04770220: An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

State
Completed
Phase
Phase 3
People
325 taking part
Started
19 May 2021
Primary completion
29 May 2024
Arms
ALZ-801
Results
Posted on the registry
  1. 25 Feb 2021: Trial registered
  2. 19 May 2021: Trial started
  3. 29 Jul 2024: Trial completed
  4. 10 Nov 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Experimental: ALZ-801.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.